Original Research
Accepted on 12 Nov 2024
Single-Cell RNA-Seq Reveals FGF12 as a Prognostic Biomarker in Low-Grade Endometrial Stromal Sarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1513076
Type at least 3 characters
6,667 articles
Articles
Review
Accepted on 12 Nov 2024
Role of rapidly evolving immunotherapy in chronic active Epstein-Barr virus disease
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1451977
Review
Accepted on 12 Nov 2024
Unravelling the druggability and immunological roles of the SOCS-family proteins
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1449397
Original Research
Accepted on 12 Nov 2024
Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1493735
Review
Published on 12 Nov 2024
Biomaterials’ enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1492323
- 383 views
Review
Published on 12 Nov 2024
From microbes to medicine: harnessing the power of the microbiome in esophageal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450927
- 259 views
Original Research
Published on 12 Nov 2024
The established of a machine learning model for predicting the efficacy of adjuvant interferon alpha1b in patients with advanced melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495329
- 256 views
Original Research
Published on 12 Nov 2024
Integrated multiomics characterization reveals cuproptosis-related hub genes for predicting the prognosis and clinical efficacy of ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1452294
- 362 views
Systematic Review
Accepted on 11 Nov 2024
Abscopal effect of focused ultrasound combined immunotherapy in animal solid tumor model: a systematic reviews and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1474343
- 103 views
Original Research
Accepted on 11 Nov 2024
Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1504459
Original Research
Accepted on 11 Nov 2024
SON-1010 -An Albumin-binding IL-12 Fusion Protein with Improved Cytokine Half-life Targets Tumors and Enhances Therapeutic Efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1493257
Review
Accepted on 11 Nov 2024
Breaking Barriers: Advancing Cellular Therapies in Autoimmune Disease Management
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1503099
Original Research
Accepted on 11 Nov 2024
Research on the effect of LAMP1 in the development and progression of ccRCC and its potential mechanism with LC3C-mediated autophagy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1494005
Clinical Trial
Accepted on 11 Nov 2024
Perioperative Tislelizumab with Four Cycles of Neoadjuvant Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase 2 Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1482005
- 103 views
Original Research
Accepted on 11 Nov 2024
PCDHGA10 as a potential prognostic biomarker and correlated with immune infiltration in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1500478
Case Report
Accepted on 11 Nov 2024
Case Report: Non-Invasive Cyto-Salivary Sampling and Biomarker Detection via ELISA versus Histopathology for Diagnosing Oral Potentially Malignant Disorders -Insights from a Case-Control Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477477